Patients
ascites, high-grade appendiceal mucinous neoplasm, neutropenia, bowel obstruction, appendiceal mucinous neoplasm, LAMN
ASCITES, NEUTROPENIA, BOWEL OBSTRUCTION, ONCOLOGY, APPENDICEAL MUCINOUS NEOPLASM
Adult patients ≥ 18 years old with histologically confirmed invasive AC or CRC with PM who had progressed on at least one previous standard chemotherapeutic treatment were included if they had Eastern Cooperative Oncology Group (ECOG) performance status (PS) ≤ 2, no contraindications for laparoscopy, and ≤ 5 L of ascites and were not a candidate for cytoreduction and/or HIPEC. Exclusion criteria were low-grade appendiceal mucinous neoplasm (LAMN) or high-grade appendiceal mucinous neoplasm (HAMN), bowel obstruction requiring nasogastric or gastrostomy tube or total parenteral nutrition, life expectancy less than 6 months, neutropenia with absolute neutrophil count (ANC) < 1500/mm